Symptoms generally associated with older adults, such as joint inflammation, chronic pain and vision loss, are affecting thousands of Australian ...

As the cost-of-living crisis intensifies, people from all walks of life are struggling. ABC Your Say asked ordinary ...

A look at the demographic drivers of Saturday’s state election result shows it’s one that should scare both (traditional) ...

Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.

More Australian children and young adults are suffering from arthritis symptoms, according to the Juvenile Arthritis ...

Discover strategies to manage fatigue from rheumatoid arthritis. Learn tips for controlling symptoms, boosting energy, and improving daily life effectively.

If the sBLA is approved, expansion into psoriatic arthritis would build on the established clinical experience of ILUMYA as an IL-23 inhibitor for moderate-to-severe ...

Immutep has completed the single ascending dose (SAD) portion of its IMP761 study IMP761 was well tolerated across all dose levels IMP761 data and Phase I results will be presented at the EULAR ...

Sun Pharmaceutical Industries Limited has announced that the US Food and Drug Administration (USFDA) has accepted for review its supplemental Biologics License Application (sBLA) ...

In this episode, Deborah Niemann welcomes back Dr. Melissa Holahan, a small ruminant veterinarian, Nigerian Dwarf breeder at ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today announced that it has regained compliance with ...

This St Patrick's Day, green beer and leprechauns are out as a new Irish identity rejects caricature in favour of authentic ...